Home › Funds › IRIDIAN ASSET MANAGEMENT LLC/CT › AXSM
IRIDIAN ASSET MANAGEMENT LLC/CT position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
IRIDIAN ASSET MANAGEMENT LLC/CT reported holding 45,129 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$8.3M, representing 3.03% of its reported portfolio and ranking #9 among its reported holdings. IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How IRIDIAN ASSET MANAGEMENT LLC/CT's AXSM position evolved
IRIDIAN ASSET MANAGEMENT LLC/CT first disclosed a stake in AXSM in Q3 2023 at 145,033 shares (US$10.1M). The position peaked in Q4 2025 at 73,783 shares, worth US$13.5M. Across 13 filings, IRIDIAN ASSET MANAGEMENT LLC/CT increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 45,129 shares valued at US$8.3M — a reduction of -2,795 shares quarter over quarter.. Notable position changes include a 29% trim in Q2 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 145.03K | $10.14M | New |
| Q4 2023 | 138.34K | $11.01M | Reduce |
| Q1 2024 | 128.84K | $10.28M | Reduce |
| Q2 2024 | 126.91K | $10.22M | Reduce |
| Q3 2024 | 126.80K | $11.40M | Hold |
| Q4 2024 | 125.08K | $10.58M | Reduce |
| Q1 2025 | 106.31K | $12.40M | Reduce |
| Q2 2025 | 91.76K | $9.58M | Reduce |
| Q3 2025 | 83.55K | $10.15M | Reduce |
| Q4 2025 | 73.78K | $13.48M | Reduce |
| Q1 2026 | 67.49K | $11.41M | Reduce |
| Q2 2026 | 47.92K | $11.73M | Reduce |
| Q3 2026 | 45.13K | $8.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 50 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K sh · $119.69M · Q3 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K sh · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
- Cannell & Spears LLC 259.65K sh · $47.88M · Q3 2026
More on IRIDIAN ASSET MANAGEMENT LLC/CT
FAQ
How long has IRIDIAN ASSET MANAGEMENT LLC/CT held AXSM?
IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is IRIDIAN ASSET MANAGEMENT LLC/CT's current position in AXSM?
As of Q3 2026, IRIDIAN ASSET MANAGEMENT LLC/CT holds 45.13K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $8.32M, representing 3.03% of its reported portfolio and ranking #9.
Has IRIDIAN ASSET MANAGEMENT LLC/CT been buying or selling AXSM?
In the latest 13F filing (Q3 2026), IRIDIAN ASSET MANAGEMENT LLC/CT reduced its position in AXSM. The position peaked in Q4 2025 at 73.78K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.